SEC 13F Intelligence

Managers / Q4 2023 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$239M
Q4 2023
Positions
39
Filings on Record
30
2019–present window
Filed
Feb 5, 2024
original filing

Summary

Sivik Global Healthcare LLC reported $239M in U.S.-listed holdings across 39 positions for Q4 2023.

Its largest position, XBI, represents 5.1% of the portfolio.

Compared with Q3 2023, the fund opened 11 new positions and exited 5.

Portfolio Metrics

Turnover
+13.3%
vs prior filed quarter
Top-10 Concentration
+39.5%
share of reported value
Largest Position
+5.1%
Spdr S P Biotech Etf
New / Exited
11 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 86.6%ADR: 6.1%ETP: 5.1%Other: 2.3%
  • Common Stock · 86.6% · $207M
  • ADR · 6.1% · $14M
  • ETP · 5.1% · $12M
  • Other · 2.3% · $6M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BIIBBiogen IncNEW+25.0K25.0K+$6M$6M
ABTAbbott LaboratoriesNEW+52.5K52.5K+$6M$6M
INSPInspire Medical Systems IncNEW+27.5K27.5K+$6M$6M
SNNSmith & Nephew PLCNEW+190.0K190.0K+$5M$5M
DVADaVita IncNEW+45.0K45.0K+$5M$5M
DGXQuest Diagnostics IncNEW+30.0K30.0K+$4M$4M
RMDResMed IncNEW+20.0K20.0K+$3M$3M
Laboratory Corp of America HoNEW+15.0K15.0K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

39 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P Biotech ETFhistory →S&P BIOTECH5.06%$12M135.6K
2THCTenet Healthcare Corphistory →COM NEW4.58%$11M145.0K
3HCAHCA Healthcare Inchistory →COM4.52%$11M40.0K
4UHSUniversal Health Services Inchistory →CLASS B4.30%$10M67.5K
5NVONovo Nordisk A/Shistory →ADR3.89%$9M90.0K
6BSXBoston Scientific Corphistory →COM3.86%$9M160.0K
7LLYEli Lilly & Cohistory →COM3.65%$9M15.0K
8SYKStryker Corphistory →COM3.50%$8M28.0K
9ISRGIntuitive Surgical Inchistory →COM NEW3.17%$8M22.5K
10ACHCAcadia Healthcare Co Inchistory →COM2.92%$7M90.0K
11MCKMcKesson Corphistory →COM2.90%$7M15.0K
12HUMHumana Inchistory →COM2.87%$7M15.0K
13MDTMedtronic PLChistory →SHS2.75%$7M80.0K
14BIIBBiogen Inchistory →COM2.70%$6M25.0K
15SGRYSurgery Partners Inchistory →COM2.67%$6M200.0K
16TMOThermo Fisher Scientific Inchistory →COM2.66%$6M12.0K
17DXCMDexcom Inchistory →COM2.59%$6M50.0K
18ZBHZimmer Biomet Holdings Inchistory →COM2.54%$6M50.0K
19EHCEncompass Health Corphistory →COM2.51%$6M90.0K
20S24Select Medical Holdings Corphistory →COM2.45%$6M250.0K
21DHRDanaher Corphistory →COM2.42%$6M25.0K
22ABTAbbott Laboratorieshistory →COM2.41%$6M52.5K
23PODDInsulet Corphistory →COM2.40%$6M26.5K
24INSPInspire Medical Systems Inchistory →COM2.34%$6M27.5K
25BMRNBioMarin Pharmaceutical Inchistory →COM2.22%$5M55.0K
26UNHUnitedHealth Group Inchistory →COM2.20%$5M10.0K
27CICigna Group/Thehistory →COM2.19%$5M17.5K
28SNNSmith & Nephew PLChistory →SPDN ADR NEW2.17%$5M190.0K
29VRTXVertex Pharmaceuticals Inchistory →COM2.12%$5M12.5K
30DVADaVita Inchistory →COM1.97%$5M45.0K
31DGXQuest Diagnostics Inchistory →COM1.73%$4M30.0K
32CORCencora Inchistory →COM1.72%$4M20.0K
33CAHCardinal Health Inchistory →COM1.68%$4M40.0K
34RMDResMed Inchistory →COM1.44%$3M20.0K
35Laboratory Corp of America HoCOM NEW1.42%$3M15.0K
36QGENQIAGEN NVSHS NEW1.00%$2M55.0K
37WBAWalgreens Boots Alliance IncCOM0.98%$2M90.0K
38Stevanato Group SpAORD SHS0.91%$2M80.0K
39MRVIMaravai LifeSciences HoldingsCOM CL A0.56%$1M205.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.